I liked the efficacy slide. imagine how it would look with 100% of the recipients on full dose
also good to see that they are seeking pharmaceutical partners to invest in next stage of trials. if successful, it will reduce dilution and validate potential. won't happen until mid next year when full results are in.
I liked the efficacy slide. imagine how it would look with 100%...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.004(5.41%) |
Mkt cap ! $19.01M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.0¢ | $14.65K | 195.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51009 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 52133 | 1 |
View Market Depth
| Last trade - 15.59pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.004 ( 4.05 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.3¢ | 7.0¢ | 2121 | ||
| Last updated 15.08pm 05/06/2024 ? | |||||
| ATX (ASX) Chart |